Form 4 Filing for Foghorn Therapeutics Inc. - Michael Mendelsohn

This filing details a Form 4 submission for Foghorn Therapeutics Inc. (FHTX) concerning transactions by Michael Mendelsohn, a director. On June 24, 2026, Mr. Mendelsohn was granted 28,000 stock options with a purchase price of $4.08 per share. These options are exercisable and vest in full on the first anniversary of the grant date, contingent upon his continued service on the board of directors. The options are for the company's Common Stock and have an expiration date of June 23, 2036. Following this transaction, Mr. Mendelsohn holds 28,000 shares of common stock underlying these options.